Daniel H. Kett

5.5k total citations · 1 hit paper
53 papers, 3.2k citations indexed

About

Daniel H. Kett is a scholar working on Epidemiology, Infectious Diseases and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Daniel H. Kett has authored 53 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 22 papers in Infectious Diseases and 15 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Daniel H. Kett's work include Nosocomial Infections in ICU (14 papers), Antifungal resistance and susceptibility (12 papers) and Pneumonia and Respiratory Infections (11 papers). Daniel H. Kett is often cited by papers focused on Nosocomial Infections in ICU (14 papers), Antifungal resistance and susceptibility (12 papers) and Pneumonia and Respiratory Infections (11 papers). Daniel H. Kett collaborates with scholars based in United States, Canada and United Kingdom. Daniel H. Kett's co-authors include Peter G. Pappas, Annette C. Reboli, Élie Azoulay, Jean‐Louis Vincent, Andrew A. Quartin, Coleman Rotstein, Thomas J. Walsh, John Rex, Barbara D. Alexander and Luis Ostrosky‐Zeichner and has published in prestigious journals such as New England Journal of Medicine, Neurology and Clinical Infectious Diseases.

In The Last Decade

Daniel H. Kett

50 papers receiving 3.1k citations

Hit Papers

Anidulafungin versus Fluconazole for Invasive Candidiasis 2007 2026 2013 2019 2007 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel H. Kett United States 23 2.1k 1.8k 434 421 369 53 3.2k
Sérgio Barsanti Wey Brazil 21 1.8k 0.9× 1.2k 0.7× 386 0.9× 473 1.1× 189 0.5× 44 2.9k
Christopher R. Frei United States 33 1.0k 0.5× 1.4k 0.8× 358 0.8× 437 1.0× 591 1.6× 151 3.5k
Koenraad Vandewoude Belgium 23 1.0k 0.5× 1.4k 0.8× 419 1.0× 664 1.6× 186 0.5× 34 2.8k
José Mensa Spain 34 2.1k 1.0× 3.2k 1.7× 438 1.0× 642 1.5× 387 1.0× 117 5.3k
Werner C. Albrich Switzerland 32 881 0.4× 2.0k 1.1× 538 1.2× 522 1.2× 168 0.5× 138 3.8k
Rafael Zaragoza Spain 26 1.2k 0.6× 1.4k 0.8× 331 0.8× 408 1.0× 167 0.5× 107 2.3k
P. Chavanet France 35 1.7k 0.8× 1.6k 0.8× 174 0.4× 158 0.4× 425 1.2× 186 3.5k
Manuel Almela Spain 24 886 0.4× 2.2k 1.2× 420 1.0× 723 1.7× 412 1.1× 51 3.5k
Paula Ramírez Spain 30 868 0.4× 1.7k 0.9× 387 0.9× 871 2.1× 305 0.8× 121 3.0k
Heinz Burgmann Austria 34 865 0.4× 1.5k 0.8× 164 0.4× 313 0.7× 618 1.7× 202 4.0k

Countries citing papers authored by Daniel H. Kett

Since Specialization
Citations

This map shows the geographic impact of Daniel H. Kett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel H. Kett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel H. Kett more than expected).

Fields of papers citing papers by Daniel H. Kett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel H. Kett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel H. Kett. The network helps show where Daniel H. Kett may publish in the future.

Co-authorship network of co-authors of Daniel H. Kett

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel H. Kett. A scholar is included among the top collaborators of Daniel H. Kett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel H. Kett. Daniel H. Kett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimose, Luis, Eriko Masuda, Maroun M. Sfeir, et al.. (2016). Carbapenem-Resistant Acinetobacter baumannii: Concomitant Contamination of Air and Environmental Surfaces. Infection Control and Hospital Epidemiology. 37(7). 777–781. 32 indexed citations
2.
Morgan, Daniel J., Lisa Pineles, Michelle Shardell, et al.. (2015). Effect of Chlorhexidine Bathing and Other Infection Control Practices on the Benefits of Universal Glove and Gown (BUGG) Trial: A Subgroup Analysis. Infection Control and Hospital Epidemiology. 36(6). 734–737. 5 indexed citations
3.
Jacob, Jesse T., Daniela Sales Alviano, Luis Felipe Reyes, et al.. (2015). Impact of Universal Gowning and Gloving on Health Care Worker Clothing Contamination. Infection Control and Hospital Epidemiology. 36(4). 431–437. 16 indexed citations
4.
Rosa, Rossana, Kristopher L. Arheart, Dennise Depascale, et al.. (2014). Environmental Exposure to Carbapenem-Resistant Acinetobacter baumannii as a Risk Factor for Patient Acquisition of A. baumannii. Infection Control and Hospital Epidemiology. 35(4). 430–433. 18 indexed citations
5.
Muñoz-Price, L. Silvia, Philip Carling, Timothy J. Cleary, et al.. (2014). Control of a two-decade endemic situation with carbapenem-resistant Acinetobacter baumannii: Electronic dissemination of a bundle of interventions. American Journal of Infection Control. 42(5). 466–471. 25 indexed citations
6.
Rosa, Rossana, Dennise Depascale, Timothy J. Cleary, et al.. (2014). Differential environmental contamination with Acinetobacter baumannii based on the anatomic source of colonization. American Journal of Infection Control. 42(7). 755–757. 17 indexed citations
7.
Quartin, Andrew A., Ernesto G. Scerpella, Sailaja Puttagunta, & Daniel H. Kett. (2013). A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study. BMC Infectious Diseases. 13(1). 561–561. 73 indexed citations
8.
Muñoz-Price, L. Silvia, Kristopher L. Arheart, Patrice Nordmann, et al.. (2013). Eighteen Years of Experience With Acinetobacter baumannii in a Tertiary Care Hospital*. Critical Care Medicine. 41(12). 2733–2742. 58 indexed citations
9.
Ferrada, Marcela A., Andrew A. Quartin, Daniel H. Kett, & Michele I. Morris. (2013). Candidemia in the critically ill: initial therapy and outcome in mechanically ventilated patients. BMC Anesthesiology. 13(1). 37–37. 10 indexed citations
10.
Kett, Daniel H., Andrew F. Shorr, Annette C. Reboli, et al.. (2011). Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis. Critical Care. 15(5). R253–R253. 78 indexed citations
11.
Kett, Daniel H., et al.. (2010). Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in intensive care unit study*. Critical Care Medicine. 39(4). 665–670. 292 indexed citations
12.
Reboli, Annette C., Coleman Rotstein, Peter G. Pappas, et al.. (2007). Anidulafungin versus Fluconazole for Invasive Candidiasis. New England Journal of Medicine. 356(24). 2472–2482. 618 indexed citations breakdown →
13.
Ostrosky‐Zeichner, Luis, Barbara D. Alexander, Daniel H. Kett, et al.. (2005). Multicenter Clinical Evaluation of the (1->3)  -D-Glucan Assay as an Aid to Diagnosis of Fungal Infections in Humans. Clinical Infectious Diseases. 41(5). 654–659. 496 indexed citations
14.
Soriano, Andres O., Wenche Jy, Julio A. Chirinos, et al.. (2005). Levels of endothelial and platelet microparticles and their interactions with leukocytes negatively correlate with organ dysfunction and predict mortality in severe sepsis. Critical Care Medicine. 33(11). 2540–2546. 140 indexed citations
15.
Cely, Cynthia, et al.. (2004). Relationship of Baseline Glucose Homeostasis to Hyperglycemia During Medical Critical Illness. CHEST Journal. 126(3). 879–887. 96 indexed citations
16.
Namias, Nicholas, Laila Samiian, Diego F. Niño, et al.. (2000). Incidence and Susceptibility of Pathogenic Bacteria Vary between Intensive Care Units within a Single Hospital: Implications for Empiric Antibiotic Strategies. The Journal of Trauma: Injury, Infection, and Critical Care. 49(4). 638–646. 81 indexed citations
17.
Kett, Daniel H., et al.. (1998). Máscara laríngea no manuseio das vias aéreas. 1 indexed citations
18.
Kett, Daniel H., Andrew A. Quartin, Charles L. Sprung, et al.. (1994). An evaluation of the hemodynamic effects of HA-1A human monoclonal antibody. Critical Care Medicine. 22(8). 1227–1234. 9 indexed citations
19.
Oster, James R., et al.. (1990). Spurious Hyperchloremia and Hyperbicarbonatemia in a Patient Receiving Pyridostigmine Bromide Therapy for Myasthenia Gravis. American Journal of Kidney Diseases. 16(1). 76–79. 9 indexed citations
20.
Schein, Roland M.H., Daniel H. Kett, Eduardo J. de Marchena, & Charles L. Sprung. (1990). Pulmonary Edema Associated with Electrical Injury. CHEST Journal. 97(5). 1248–1250. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026